NGM·Healthcare·$134M·#251 / 520 in Healthcare
HYPR Hyperfine, Inc.
44SPECULATIVE
CATEGORY BREAKDOWN
GROWTH8
QUALITY42
STABILITY68
VALUATION51
GOVERNANCE45
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+5.2%
8
> 50% strong
Gross Margin
Revenue retained after direct costs
49.8%
70
> 50% strong
Cash Runway
Months of cash at current burn rate
15 months
53
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
0.6%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
8.7x
51
< 3x strong
Rule of 40
Growth rate plus operating margin
-268
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.8%
39
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+7.2%
57
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE HYPR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when HYPR's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.